Apoptotic Machinery Diversity in Multiple Myeloma Molecular Subtypes

ανά Gomez-Bougie, Patricia, Amiot, Martine
Έκδοση 2013

Targeting Oxidative Stress With Auranofin or Prima-1(Met) to Circumvent p53 or Bax/Bak Deficiency in Myeloma Cells

ανά Tessoulin, Benoit, Descamps, Geraldine, Dousset, Christelle, Amiot, Martine, Pellat-Deceunynck, Catherine
Τόπος έκδοσης Front Oncol (2019)

TLR9 Ligand Induces the Generation of CD20+ Plasmablasts and Plasma Cells from CD27+ Memory B-Cells

ανά Geffroy-Luseau, Alexandrine, Chiron, David, Descamps, Géraldine, Jégo, Gaëtan, Amiot, Martine, Pellat-Deceunynck, Catherine
Έκδοση 2011

BCL2-Family Dysregulation in B-Cell Malignancies: From Gene Expression Regulation to a Targeted Therapy Biomarker

ανά Tessoulin, Benoît, Papin, Antonin, Gomez-Bougie, Patricia, Bellanger, Celine, Amiot, Martine, Pellat-Deceunynck, Catherine, Chiron, David
Τόπος έκδοσης Front Oncol (2019)

Curcumin induces cell death of the main molecular myeloma subtypes, particularly the poor prognosis subgroups

ανά Gomez-Bougie, Patricia, Halliez, Maxime, Maïga, Sophie, Godon, Catherine, Kervoëlen, Charlotte, Pellat-Deceunynck, Catherine, Moreau, Philippe, Amiot, Martine
Τόπος έκδοσης Cancer Biol Ther (2014)

Biological rational for sequential targeting of Bruton tyrosine kinase and Bcl-2 to overcome CD40-induced ABT-199 resistance in mantle cell lymphoma

ανά Chiron, David, Dousset, Christelle, Brosseau, Carole, Touzeau, Cyrille, Maïga, Sophie, Moreau, Philippe, Pellat-Deceunynck, Catherine, Le Gouill, Steven, Amiot, Martine
Τόπος έκδοσης Oncotarget (2015)

Found in translation: how preclinical research is guiding the clinical development of the BCL-2-selective inhibitor venetoclax

ανά Leverson, Joel D., Sampath, Deepak, Souers, Andrew J., Rosenberg, Saul H., Fairbrother, Wayne J., Amiot, Martine, Konopleva, Marina, Letai, Anthony
Τόπος έκδοσης Cancer Discov (2017)

Dexamethasone-induced cell death is restricted to specific molecular subgroups of multiple myeloma

ανά Kervoëlen, Charlotte, Ménoret, Emmanuelle, Gomez-Bougie, Patricia, Bataille, Régis, Godon, Catherine, Marionneau-Lambot, Séverine, Moreau, Philippe, Pellat-Deceunynck, Catherine, Amiot, Martine
Τόπος έκδοσης Oncotarget (2015)

The REFRACT-LYMA cohort study: a French observational prospective cohort study of patients with mantle cell lymphoma

ανά Hanf, Matthieu, Chiron, David, de Visme, Sophie, Touzeau, Cyrille, Maisonneuve, Hervé, Jardel, Henry, Pellat-Deceunynck, Catherine, Amiot, Martine, le Gouill, Steven
Τόπος έκδοσης BMC Cancer (2016)

Deep and sustained response after venetoclax therapy in a patient with very advanced refractory myeloma with translocation t(11;14)

ανά Touzeau, Cyrille, Le Gouill, Steven, Mahé, Béatrice, Boudreault, Jean Samuel, Gastinne, Thomas, Blin, Nicolas, Caillon, Hélène, Dousset, Christelle, Amiot, Martine, Moreau, Philippe
Τόπος έκδοσης Haematologica (2017)

BH3-profiling identifies heterogeneous dependency on Bcl-2 family members in Multiple Myeloma and predicts sensitivity to BH3 mimetics

ανά Touzeau, Cyrille, Ryan, Jeremy, Guerriero, Jennifer L., Moreau, Philippe, Chonghaile, Triona Ni, Gouill, Steven Le, Richardson, Paul, Anderson, Kenneth, Amiot, Martine, Letai, Anthony
Τόπος έκδοσης Leukemia (2015)

Dual targeting of BCL2 and MCL1 rescues myeloma cells resistant to BCL2 and MCL1 inhibitors associated with the formation of BAX/BAK hetero-complexes

ανά Seiller, Carolane, Maiga, Sophie, Touzeau, Cyrille, Bellanger, Céline, Kervoëlen, Charlotte, Descamps, Géraldine, Maillet, Laurent, Moreau, Philippe, Pellat-Deceunynck, Catherine, Gomez-Bougie, Patricia, Amiot, Martine
Τόπος έκδοσης Cell Death Dis (2020)

A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines

ανά Moreaux, Jérôme, Klein, Bernard, Bataille, Régis, Descamps, Géraldine, Maïga, Sophie, Hose, Dirk, Goldschmidt, Hartmut, Jauch, Anna, Rème, Thierry, Jourdan, Michel, Amiot, Martine, Pellat-Deceunynck, Catherine
Έκδοση 2011

Decitabine and Melphalan Fail to Reactivate p73 in p53 Deficient Myeloma Cells

ανά Gillardin, Pierre-Samuel, Descamps, Géraldine, Maiga, Sophie, Tessoulin, Benoit, Djamai, Hanane, Lucani, Benedetta, Chiron, David, Moreau, Philippe, Le Gouill, Steven, Amiot, Martine, Pellat-Deceunynck, Catherine, Moreau-Aubry, Agnès
Τόπος έκδοσης Int J Mol Sci (2017)

Whole-exon sequencing of human myeloma cell lines shows mutations related to myeloma patients at relapse with major hits in the DNA regulation and repair pathways

ανά Tessoulin, Benoît, Moreau-Aubry, Agnès, Descamps, Géraldine, Gomez-Bougie, Patricia, Maïga, Sophie, Gaignard, Alban, Chiron, David, Ménoret, Emmanuelle, Le Gouill, Steven, Moreau, Philippe, Amiot, Martine, Pellat-Deceunynck, Catherine
Τόπος έκδοσης J Hematol Oncol (2018)

The MYRACLE protocol study: a multicentric observational prospective cohort study of patients with multiple myeloma

ανά Benaniba, Lina, Tessoulin, Benoit, Trudel, Sabrina, Pellat-Deceunynck, Catherine, Amiot, Martine, Minvielle, Stéphane, Gourraud, Pierre Antoine, de Visme, Sophie, Maisonneuve, Hervé, Lok, Anne, Le Gouill, Steven, Moreau, Philippe, Touzeau, Cyrille
Τόπος έκδοσης BMC Cancer (2019)

RITA (Reactivating p53 and Inducing Tumor Apoptosis) is efficient against TP53(abnormal) myeloma cells independently of the p53 pathway

ανά Surget, Sylvanie, Descamps, Géraldine, Brosseau, Carole, Normant, Vincent, Maïga, Sophie, Gomez-Bougie, Patricia, Gouy-Colin, Nadège, Godon, Catherine, Béné, Marie C, Moreau, Philippe, Le Gouill, Steven, Amiot, Martine, Pellat-Deceunynck, Catherine
Έκδοση 2014

The anti-tumoral effect of lenalidomide is increased in vivo by hypoxia-inducible factor (HIF)-1α inhibition in myeloma cells

ανά Storti, Paola, Toscani, Denise, Airoldi, Irma, Marchica, Valentina, Maiga, Sophie, Bolzoni, Marina, Fiorini, Elena, Campanini, Nicoletta, Martella, Eugenia, Mancini, Cristina, Guasco, Daniela, Ferri, Valentina, Donofrio, Gaetano, Aversa, Franco, Amiot, Martine, Giuliani, Nicola
Τόπος έκδοσης Haematologica (2016)

p53 regulates CD46 expression and measles virus infection in myeloma cells

ανά Lok, Anne, Descamps, Geraldine, Tessoulin, Benoit, Chiron, David, Eveillard, Marion, Godon, Catherine, Le Bris, Yannick, Vabret, Astrid, Bellanger, Celine, Maillet, Laurent, Barillé-Nion, Sophie, Gregoire, Marc, Fonteneau, Jean-François, Le Gouill, Steven, Moreau, Philippe, Tangy, Frederic, Amiot, Martine, Moreau-Aubry, Agnes, Pellat-Deceunynck, Catherine
Τόπος έκδοσης Blood Adv (2018)

BCL-B (BCL2L10) is overexpressed in patients suffering from multiple myeloma (MM) and drives an MM-like disease in transgenic mice

ανά Hamouda, Mohamed-Amine, Jacquel, Arnaud, Robert, Guillaume, Puissant, Alexandre, Richez, Valentine, Cassel, Romeo, Fenouille, Nina, Roulland, Sandrine, Gilleron, Jerome, Griessinger, Emmanuel, Dubois, Alix, Bailly-Maitre, Beatrice, Goncalves, Diogo, Mallavialle, Aude, Colosetti, Pascal, Marchetti, Sandrine, Amiot, Martine, Gomez-Bougie, Patricia, Rochet, Nathalie, Deckert, Marcel, Avet-Loiseau, Herve, Hofman, Paul, Karsenti, Jean-Michel, Jeandel, Pierre-Yves, Blin-Wakkach, Claudine, Nadel, Bertrand, Cluzeau, Thomas, Anderson, Kenneth C., Fuzibet, Jean-Gabriel, Auberger, Patrick, Luciano, Frederic
Τόπος έκδοσης J Exp Med (2016)